Medical Patent News

RSS

Nanosys reaches settlement of patent infringement lawsuit against Nanoco Technologies

Nanosys, Inc. today announced it has agreed to settlement terms of a patent infringement lawsuit against Nanoco Technologies Ltd.

23 Jul 2009

NovaSterilis receives patent for vaccine creation using supercritical carbon dioxide

NovaSterilis Inc., a developer of supercritical carbon dioxide technology for biomedical applications, announces the issue of US Patent 7,560,113 for creation and production of whole cell vaccines with supercritical carbon dioxide (SCCO2)*.

22 Jul 2009

Watson confirms new drug application for generic Sanctura XR

Watson Pharmaceuticals, Inc. has confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its trospium chloride extended-release 60 mg capsules prior to the expiration of a patent owned by Supernus Pharmaceuticals, Inc.

15 Jul 2009

Circadian Technologies granted significant European patent

Circadian Technologies Limited (ASX:CIR) announced today that its subsidiary company, Vegenics Limited, has been granted European Patent 1749836 covering the use of VEGF-D protein and antibodies to VEGF-D in a broad spectrum of therapeutic indications, including the treatment of cancer.

17 Jun 2009

Misonix purchase patents from ProRhythm

Misonix, Inc. has announced that it has purchased three patents associated with High Intensity Focused Ultrasound ("HIFU") technology from ProRhythm, Inc.

14 Jun 2009

Impliant granted two new U.S. patents - successfully defends European patent

Impliant, Inc., a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that the European Patent Office has confirmed the validity of one of its key patents following an Opposition by Archus Orthopedics, Inc. (Redmond, WA) that concluded with oral proceedings on May 12, 2009 in Munich, Germany.

9 Jun 2009

Medtronic announces appeal decision in patent case with DePuy Spine

Medtronic, Inc. has announced results from a Federal Circuit Court review of a December 2007 patent infringement verdict regarding the Vertex line of multiaxial screws, which are no longer on the market.

1 Jun 2009

New U.S. patent issued for Limbrel in osteoarthritis

Primus Pharmaceuticals, Inc. has announced the issuance of a new composition of matter patent for Limbrel, the first prescription medical food product to safely meet the distinctive nutritional requirements of patients with osteoarthritis (OA). U.S. Patent #7,514,469 was recently issued by the U.S. Patent and Trademark Office.

27 May 2009

Viral Genetics issued patent for novel cancer therapies

Biotechnology firm Viral Genetics, Inc. has been issued a patent for novel cancer therapies. The patent protects cancer drugs that have been tested in pre-clinical research studies in mice. Issued on March 31, 2009, the U.S. Patent Number is: 7,510,710. Additional patents directed at generic classes of the drugs are still pending.

22 May 2009

AstraZeneca granted preliminary injunction against Apotex in Pulmicort Respules patent litigation

On May 20, 2009, the US District Court for the District of New Jersey granted the request of AstraZeneca for an injunction barring Apotex (Apotex, Inc. and Apotex Corp.) from launching a generic version of AstraZeneca's Pulmicort Respules (budesonide inhalation suspension) in the US. No trial date for the patent litigation has been set.

20 May 2009

Resverlogix files two patents on compounds for inflammatory diseases

Resverlogix Corp. has announced today that it has made significant advancement in the Company's research and development (R&D) program for inflammatory diseases.

19 May 2009

Atherotech receives patent for ApoB measurement for determining heart disease risk

Atherotech, Inc., developer of the VAP Cholesterol Test, has announced it has received a patent on its method to derive and report apolipoprotein B100 (apoB) using the Vertical Auto Profile (VAP) technology. The patent recognizes the unique ability of the VAP Cholesterol Test to accurately report apoB, the next milestone in heart disease risk assessment.

19 May 2009

Intradigm issued RNA interference (RNAi) patent covering potent siRNA sequence

Intradigm Corporation has announced the issuance of United States patent 7,534,878, titled "Composition and Methods of RNAi Therapeutics for Treatment of Cancer and Other Neovascularization Diseases."

19 May 2009

U.S. Patent Office upholds StemCells’ patents

StemCells, Inc. has announced that the U.S. Patent and Trademark Office (PTO) has upheld the validity of the remaining two neural stem cell patents which were subjected to reexamination proceedings commenced by Neuralstem, Inc.

17 May 2009

American Civil Liberties Union challenges breast cancer gene patents

The American Civil Liberties Union and the Public Patent Foundation at Benjamin N. Cardozo School of Law (PUBPAT) filed a lawsuit today charging that patents on two human genes associated with breast and ovarian cancer stifle research that could lead to cures and limit women's options regarding their medical care.

12 May 2009

Wistar Institute obtains U.S. patent for a novel synthetic vaccine technology

The Wistar Institute today obtained a U.S. patent for a novel synthetic vaccine technology with the potential for further development into a universal flu vaccine which could eliminate the need for annual flu shots and protect against future flu pandemics.

6 May 2009

Medical Patent News

Nanosys reaches settlement of patent infringement lawsuit against Nanoco Technologies

NovaSterilis receives patent for vaccine creation using supercritical carbon dioxide

Watson confirms new drug application for generic Sanctura XR

Circadian Technologies granted significant European patent

Misonix purchase patents from ProRhythm

Impliant granted two new U.S. patents - successfully defends European patent

Medtronic announces appeal decision in patent case with DePuy Spine

New U.S. patent issued for Limbrel in osteoarthritis

Viral Genetics issued patent for novel cancer therapies

AstraZeneca granted preliminary injunction against Apotex in Pulmicort Respules patent litigation

Resverlogix files two patents on compounds for inflammatory diseases

Atherotech receives patent for ApoB measurement for determining heart disease risk

Intradigm issued RNA interference (RNAi) patent covering potent siRNA sequence

U.S. Patent Office upholds StemCells’ patents

American Civil Liberties Union challenges breast cancer gene patents

Wistar Institute obtains U.S. patent for a novel synthetic vaccine technology

Acclarent granted key patent covering balloon sinuplasty technologies

Sinobiopharma secures rights to seven key patents

Amnis receives patent for blood and cell analysis using an imaging flow cytometer

Star Scientific reports on patent application for Zero-Nitrosamine tobacco curing process

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News